Andrew Galler
Stock Analyst at Morgan Stanley
(0.58)
# 3,910
Out of 4,876 analysts
29
Total ratings
33.33%
Success rate
-15.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Equal-Weight | $35 | $32.15 | +8.88% | 13 | Mar 7, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $5.70 | +163.16% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $5.52 | +226.09% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $16.13 | +129.39% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $39.85 | +40.53% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $5.26 | +242.21% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $49.45 | +9.20% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $52.41 | -4.60% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $2.68 | +1,541.79% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $27.82 | +992.74% | 1 | Nov 9, 2021 |
Immunocore Holdings
Mar 7, 2025
Assumes: Equal-Weight
Price Target: $35
Current: $32.15
Upside: +8.88%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $5.70
Upside: +163.16%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $5.52
Upside: +226.09%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $16.13
Upside: +129.39%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $39.85
Upside: +40.53%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $5.26
Upside: +242.21%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $49.45
Upside: +9.20%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $52.41
Upside: -4.60%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $2.68
Upside: +1,541.79%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $27.82
Upside: +992.74%